Tenet Healthcare (NYSE:THC) Issues FY 2025 Earnings Guidance

Tenet Healthcare (NYSE:THC) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 11.740-12.840 for the period, compared to the consensus earnings per share estimate of 11.080. The company issued revenue guidance of $20.6 billion-$21.0 billion, compared to the consensus revenue estimate of $21.3 billion.

Tenet Healthcare Trading Up 1.9 %

Shares of THC traded up $2.42 during mid-day trading on Thursday, reaching $128.61. The company’s stock had a trading volume of 311,252 shares, compared to its average volume of 1,140,141. The stock has a market cap of $12.23 billion, a PE ratio of 4.12, a P/E/G ratio of 0.63 and a beta of 2.05. Tenet Healthcare has a 52 week low of $87.06 and a 52 week high of $171.20. The company has a current ratio of 1.58, a quick ratio of 1.52 and a debt-to-equity ratio of 2.35. The company’s fifty day moving average price is $133.55 and its two-hundred day moving average price is $148.37.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Wednesday, February 12th. The company reported $3.44 EPS for the quarter, beating the consensus estimate of $2.95 by $0.49. Tenet Healthcare had a return on equity of 24.05% and a net margin of 14.91%. On average, analysts predict that Tenet Healthcare will post 11.37 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on THC shares. Barclays lowered their price target on Tenet Healthcare from $190.00 to $161.00 and set an “overweight” rating on the stock in a report on Thursday. Raymond James cut shares of Tenet Healthcare from a “strong-buy” rating to an “outperform” rating and set a $195.00 price target on the stock. in a report on Friday, November 22nd. UBS Group lifted their price objective on Tenet Healthcare from $197.00 to $217.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Royal Bank of Canada increased their target price on Tenet Healthcare from $174.00 to $183.00 and gave the company an “outperform” rating in a research report on Wednesday, October 30th. Finally, StockNews.com downgraded Tenet Healthcare from a “strong-buy” rating to a “buy” rating in a report on Tuesday, December 17th. Three investment analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, Tenet Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $163.19.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.